BackDeciphera Pharmaceuticals Overview

Deciphera Pharmaceuticals Other Income Expense Net

Other Income/Expense Net for DCPH.

Quarterly Other Income/Expense

$3.76M
↑ 3.18% YoY

As of Mar 31, 2024

Annual Other Income/Expense (TTM)

$16.56M
↑ 354.03% YoY

Trailing 12 months ending Mar 31, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin